Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Widespread epigenetic changes to the enhancer landscape of mouse liver induced by a specific xenobiotic agonist ligand of the nuclear receptor CAR.

Rampersaud A, Lodato NJ, Shin A, Waxman DJ.

Toxicol Sci. 2019 Jun 24. pii: kfz148. doi: 10.1093/toxsci/kfz148. [Epub ahead of print]

PMID:
31236583
2.

Fluorescent nanodiamonds for luminescent thermometry in the biological transparency window.

Alkahtani MH, Alghannam F, Jiang L, Rampersaud AA, Brick R, Gomes CL, Scully MO, Hemmer PR.

Opt Lett. 2018 Jul 15;43(14):3317-3320. doi: 10.1364/OL.43.003317.

PMID:
30004495
3.

Impact of CAR Agonist Ligand TCPOBOP on Mouse Liver Chromatin Accessibility.

Lodato NJ, Rampersaud A, Waxman DJ.

Toxicol Sci. 2018 Jul 1;164(1):115-128. doi: 10.1093/toxsci/kfy070.

4.

Fluorescent nanodiamond-bacteriophage conjugates maintain host specificity.

Trinh JT, Alkahtani MH, Rampersaud I, Rampersaud A, Scully M, Young RF, Hemmer P, Zeng L.

Biotechnol Bioeng. 2018 Jun;115(6):1427-1436. doi: 10.1002/bit.26573. Epub 2018 Mar 8.

5.
6.

Activation of Male Liver Chromatin Accessibility and STAT5-Dependent Gene Transcription by Plasma Growth Hormone Pulses.

Connerney J, Lau-Corona D, Rampersaud A, Waxman DJ.

Endocrinology. 2017 May 1;158(5):1386-1405. doi: 10.1210/en.2017-00060.

7.

Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy.

Suarez-Kelly LP, Campbell AR, Rampersaud IV, Bumb A, Wang MS, Butchar JP, Tridandapani S, Yu L, Rampersaud AA, Carson WE 3rd.

Nanomedicine. 2017 Apr;13(3):909-920. doi: 10.1016/j.nano.2016.12.005. Epub 2016 Dec 18.

8.

Electron Paramagnetic Resonance of a Single NV Nanodiamond Attached to an Individual Biomolecule.

Teeling-Smith RM, Jung YW, Scozzaro N, Cardellino J, Rampersaud I, North JA, Šimon M, Bhallamudi VP, Rampersaud A, Johnston-Halperin E, Poirier MG, Hammel PC.

Biophys J. 2016 May 10;110(9):2044-52. doi: 10.1016/j.bpj.2016.03.022.

9.

Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.

O'Connor GM, Yamada E, Rampersaud A, Thomas R, Carrington M, McVicar DW.

J Immunol. 2011 Sep 1;187(5):2162-71. doi: 10.4049/jimmunol.1002906. Epub 2011 Jul 29.

10.

Diffusion characteristics of microfabricated silicon nanopore membranes as immunoisolation membranes for use in cellular therapeutics.

Smith C, Kirk R, West T, Bratzel M, Cohen M, Martin F, Boiarski A, Rampersaud AA.

Diabetes Technol Ther. 2005 Feb;7(1):151-62.

PMID:
15738713
11.

Nanoporous microsystems for islet cell replacement.

Desai TA, West T, Cohen M, Boiarski T, Rampersaud A.

Adv Drug Deliv Rev. 2004 Sep 22;56(11):1661-73. Review.

PMID:
15350295
12.

Gangliosides and growth factor receptor regulation.

Rampersaud AA, Oblinger JL, Ponnappan RK, Burry RW, Yates AJ.

Biochem Soc Trans. 1999 Aug;27(4):415-22. Review. No abstract available.

PMID:
10917613
13.

GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells.

Farooqui T, Kelley T, Coggeshall KM, Rampersaud AA, Yates AJ.

Anticancer Res. 1999 Nov-Dec;19(6B):5007-13.

PMID:
10697503
15.

Synthesis and in vitro biological activity of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha-ol: a 24,25-dehydro analog of the hypocholesterolemic agent 4alpha-(2-propenyl)-5alpha-cholestan-3alpha-ol.

Lin HS, Rampersaud AA, Richett ME, Harper RW, Beavers LS, McClure DB, Gardner AJ, Eacho PI, Foxworthy PS, Gadski RA.

Steroids. 1999 Mar;64(3):217-27.

PMID:
10400383
16.

GM1 activates the MAP kinase cascade through a novel wortmannin-sensitive step upstream from c-Raf.

Rampersaud AA, Van Brocklyn JR, Yates AJ.

Ann N Y Acad Sci. 1998 Jun 19;845:424. No abstract available.

PMID:
9668387
17.

Expression of recombinant beta-platelet-derived growth-factor receptor in Sf9 insect cells as a model to study receptor-ganglioside interactions.

McGee SW, Saqr HE, Hynds DL, Rampersaud AA, Yates AJ.

Ann N Y Acad Sci. 1998 Jun 19;845:417. No abstract available.

PMID:
9668383
18.

Sphingolipids as receptor modulators. An overview.

Yates AJ, Rampersaud A.

Ann N Y Acad Sci. 1998 Jun 19;845:57-71. Review.

PMID:
9668343
19.
20.

Ganglioside GM1 activates the mitogen-activated protein kinase Erk2 and p70 S6 kinase in U-1242 MG human glioma cells.

Van Brocklyn JR, Vandenheede JR, Fertel R, Yates AJ, Rampersaud AA.

J Neurochem. 1997 Jul;69(1):116-25.

21.

Synthesis and biological evaluation of a new series of sterols as potential hypocholesterolemic agents.

Lin HS, Rampersaud AA, Archer RA, Pawlak JM, Beavers LS, Schmidt RJ, Kauffman RF, Bensch WR, Bumol TF, Apelgren LD, et al.

J Med Chem. 1995 Jan 20;38(2):277-88.

PMID:
7830271
23.
24.

Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene.

Omiecinski CJ, Ramsden R, Rampersaud A, Walz FG Jr.

Mol Pharmacol. 1992 Aug;42(2):249-56.

PMID:
1513322
26.

Observations on the synthesis and in vivo photodynamic activity of some benzochlorins.

Morgan AR, Skalkos D, Maguire G, Rampersaud A, Garbo G, Keck R, Selman SH.

Photochem Photobiol. 1992 Jan;55(1):133-6.

PMID:
1603843
28.

Ca2(+)-enhanced phosphorylation of a chimeric protein kinase involved with bacterial signal transduction.

Rampersaud A, Utsumi R, Delgado J, Forst SA, Inouye M.

J Biol Chem. 1991 Apr 25;266(12):7633-7.

29.

Characterization of distinct angiotensin II binding sites in rat adrenal gland and bovine cerebellum using selective nonpeptide antagonists.

Wiest SA, Rampersaud A, Zimmerman K, Steinberg MI.

J Cardiovasc Pharmacol. 1991 Feb;17(2):177-84.

PMID:
1709220
30.

In vivo phosphorylation of OmpR, the transcription activator of the ompF and ompC genes in Escherichia coli.

Forst S, Delgado J, Rampersaud A, Inouye M.

J Bacteriol. 1990 Jun;172(6):3473-7.

31.
32.

Activation of bacterial porin gene expression by a chimeric signal transducer in response to aspartate.

Utsumi R, Brissette RE, Rampersaud A, Forst SA, Oosawa K, Inouye M.

Science. 1989 Sep 15;245(4923):1246-9.

PMID:
2476847
33.

New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effect on normal tissue.

Morgan AR, Rampersaud A, Garbo GM, Keck RW, Selman SH.

J Med Chem. 1989 Apr;32(4):904-8.

PMID:
2704035
34.

Verdins: new photosensitizers for photodynamic therapy.

Morgan AR, Rampersaud A, Keck RW, Selman SH.

Photochem Photobiol. 1987 Sep;46(3):441-4. No abstract available.

PMID:
3671515
35.

Polymorphisms of four hepatic cytochromes P-450 in twenty-eight inbred strains of rat.

Rampersaud A, Walz FG Jr.

Biochem Genet. 1987 Aug;25(7-8):527-34.

PMID:
3447587
37.

A regulatory polymorphism for rat hepatic cytochrome P-450g.

Rampersaud A, Bandiera S, Ryan DE, Levin W, Thomas PE, Walz FG Jr.

Arch Biochem Biophys. 1987 Jan;252(1):145-51.

PMID:
3813531
38.

Cytochrome P-450 polypeptides in pulmonary microsomes from rats.

Rampersaud A, Walz FG Jr.

Biochim Biophys Acta. 1986 Feb 14;869(3):293-303.

PMID:
3947639
39.

Microheterogeneity of a male-specific rat hepatic cytochrome P-450: existence of three allozymic forms.

Rampersaud A, Waxman DJ, Ryan DE, Levin W, Walz FG Jr.

Arch Biochem Biophys. 1985 Nov 15;243(1):174-83.

PMID:
3840669
40.

Supplemental Content

Loading ...
Support Center